Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CD9 | P21926 | CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9) | Cancer-related genesCD markersPlasma proteins | 4 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 424 | 0.88 | |||
| CD81 | P60033 | CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81) | CD markersDisease related genesHuman disease related genes | 4 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 305 | 0.88 | |||
| EHD1 | Q9H4M9 | EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin) | Plasma proteinsPredicted intracellular proteinsTransporters | Fusion and delivery mediationImmune mediation | 114 | 0.88 | ||||
| LAT1 | Q01650 | Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 67 | 0.88 | |||
| CD44 | P16070 | CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44) | Blood group antigen proteinsCancer-related genesCD markers | 1 | Ovarian cancerRetinopathySolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 64 | 0.88 | ||
| PARVB | Q9HBI1 | Beta-parvin (Affixin) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationReceptor-signaling mediation | 55 | 0.88 | ||||
| MYH9 | P35579 | Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) | Cancer-related genesDisease related genesHuman disease related genes | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 52 | 0.88 | ||||
| CLIC4 | Q9Y696 | Chloride intracellular channel protein 4 (Glutaredoxin-like oxidoreductase CLIC4) (EC 1.8.-.-) (Intracellular chloride ion channel protein p64H1) | Predicted intracellular proteinsTransporters | 1 | Clinical-translation mediationFusion and delivery mediation | 41 | 0.88 | |||
| KCC2D | Q13557 | Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) | EnzymesPlasma proteinsPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 41 | 0.88 | ||||
| COF1 | P23528 | Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform) | Essential proteinsPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 37 | 0.88 | ||||
| RAB25 | P57735 | Ras-related protein Rab-25 (EC 3.6.5.2) (CATX-8) | Cancer-related genesPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 37 | 0.88 | ||||
| STRN3 | Q13033 | Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen) | Plasma proteinsPredicted intracellular proteins | Other mediation | 36 | 0.88 | ||||
| BASP1 | P80723 | Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22) | Plasma proteinsPredicted intracellular proteinsTransporters | Receptor-signaling mediation | 34 | 0.88 | ||||
| P4K2A | Q9BTU6 | Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha) | EnzymesMetabolic proteinsPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 34 | 0.88 | ||||
| EHD4 | Q9H223 | EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediation | 33 | 0.88 | ||||
| TSN15 | O95858 | Tetraspanin-15 (Tspan-15) (Tetraspan NET-7) (Transmembrane 4 superfamily member 15) | Predicted membrane proteinsTransporters | 4 | Fusion and delivery mediationMetabolism mediation | 32 | 0.88 | |||
| CTNA1 | P35221 | Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13) | Disease related genesHuman disease related genesPlasma proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 30 | 0.88 | ||||
| CD109 | Q6YHK3 | CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109) | CD markersPlasma proteinsPredicted membrane proteins | Fusion and delivery mediationImmune mediationMetabolism mediation | 29 | 0.88 | ||||
| CD47 | Q08722 | Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 5 | Acute myeloid leukaemiaB-cell lymphomaColorectal cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 29 | 0.88 | ||
| PACN2 | Q9UNF0 | Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II) (SdpII) | Predicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediation | 29 | 0.88 | ||||
| DBNL | Q9UJU6 | Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 28 | 0.88 | ||||
| E41L2 | O43491 | Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | Adhesion and uptake mediationFusion and delivery mediation | 27 | 0.88 | ||||
| VANG1 | Q8TAA9 | Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) | Disease related genesHuman disease related genesPotential drug targets | 4 | Receptor-signaling mediation | 26 | 0.88 | |||
| AAAT | Q15758 | Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) | FDA approved drug targetsMetabolic proteinsPlasma proteins | 8 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 25 | 0.88 | |||
| PODXL | O00592 | Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1) | Plasma proteinsPredicted membrane proteinsTransporters | 1 | Adhesion and uptake mediationFusion and delivery mediation | 24 | 0.88 |